Oct 19, 2015
A nonprofit network dedicated to finding a cure for Alzheimer’s — WomenAgainstAlzheimer’s and UsAgainstAlzheimer’s — recently presented the firm with the Inaugural Corporate Changemaker award.
The award honors a global leader that is committed to accelerating innovation in Alzheimer’s treatments and care while demonstrating a willingness to change the business-as-usual approach to ending the disease.
JPMorgan Chase created the Dementia Discovery Fund, a public-private global fund that is first-of-a-kind in investing in preclinical Alzheimer's work. The $100 million fund intends to improve the likelihood of identifying treatments to slow the progression of Alzheimer’s and improve the quality of life of patients and, by extension, their caregivers.
The fund is a unique collaboration, bringing together the combined expertise of government, financial, industry and charity partners. It is part of a broader effort supported by the World Dementia Council, which works to improve regulatory pathways and data sharing across research organizations.